Triple vs. Dual Therapy

NCT02080858 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation
Acute Coronary Syndrome

Interventions

DRUG: Ticagrelor + Apixaban + ASA
DRUG: Ticagrelor + Apixaban

Sponsor

Medical University of Vienna